Sign up USA
Proactive Investors - Run By Investors For Investors

WeedMD partners with world-renowned Technion-Israel Institute of Technology for cannabis research project

Technion is widely recognized as one of the global leaders in medical cannabis research
cannabis leaves
The project will research the profiles of 25 of WeedMD’s cannabis strains

Canadian marijuana producer and distributor WeedMD Inc (CVE:WMD) has joined the world-renowned Cannabis Database Project led by the Technion-Israel Institute of Technology.

Those in the project will be collaborating in the research of cannabinoid and terpenoid profiles of 25 of WeedMD’s cannabis strains.

READ: WeedMD now selling medical cannabis oil

This data will then be added to an international database that correlates the pharmacological effects of the different strains.

From there, the most effective cannabis treatments - strains, dose and route of administration - for clinical purposes can be determined.

This is the first of several research and development initiatives WeedMD is working on as the firm develops its medical cannabis for both the domestic and global markets.

“We are proud to be at the forefront of investing in cannabis research, awareness and education,” said chief scientific officer Luc Duchesne.

“There are hundreds of cannabis strains available to medical patients, but each of these strains has a unique chemical profile, as well potentially unique medical properties.

“A significant barrier to the standardization of medical cannabis is identifying strains that are effective in the treatment of specific medical conditions and Technion is making ground-breaking discoveries to this effect.”

WeedMD shares rose 3.7% to C$2.26 on Wednesday morning.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Related Articles

Kaneh Bosom Biotechnology: experienced management, access to capital and a clear strategy paves the
August 13 2018
The company says access to capital and a clear strategy will help it succeed

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use